Hesco: compound amino acid injection (18AA-Ⅶ) was evaluated by generic drug consistency.

[Heiscox: compound Amino Acid injection (18AA-Ⅶ) passes generic consistency Evaluation] Hesco announced that the compound Amino Acid injection (18AA-Ⅶ) of Shenyang Haiske Pharmaceutical Co., Ltd., a wholly owned grandson company, has passed the evaluation of generic drug quality and efficacy consistency. The product is intended for hypoproteinemia, hyponutritional status and amino acid supplementation before and after surgery.